The invention relates to a linear polyglycerol compound, comprising a backbone of linearly linked glycerol residues. This compound is characterized in that it carries a plurality of substituents in the nature of covalently bound sulfates, wherein a degree of substitution of the backbone is preferably between 30 and 100%. A method of manufacturing the compound as well as uses of this compound and similar compounds are also disclosed.

This invention relates to the use of base-labile protecting groups for stepwise synthesis of polymers including oligomers. One or more monomers that have a base-labile protecting group at one end and a leaving group at the other are used in synthetic cycles comprising deprotection under stronger basic conditions to remove the base-labile protecting group, and coupling with a monomer under weaker basic conditions to elongate the polymer without premature deprotection of the base-labile protecting group. Advantages of the invention include the possibility to shorten the synthetic cycle from three steps in prior art methods to two steps, more efficient deprotection, more efficient coupling, and the use of less harmful and less expensive chemicals. One of the goals for stepwise polymer synthesis is to prepare monodisperse and sequence-defined polymers.

A preparation method of a hydrogel of a mercapto-modified macromolecular compound includes the steps of combining the mercapto-modified macromolecular compound with an acrylated macromolecular compound and/or an acrylated micromolecular crosslinker. The mercapto-modified macromolecular compound can be crosslinked with the acrylated macromolecular compound and/or the acrylated micromolecular crosslinker under physiological conditions to form the hydrogel. Due to the rapid mercapto-vinyl crosslinking reaction, the formed hydrogel system can be quickly gelled in situ after being injected into the body. The hydrogel is thus suitable for use in the fields of biomedicine, medical cosmetic plastic surgery and cosmetics.

According to one aspect of the present invention, an organic fluorine compound is represented by a general formula
(R-π-E-CH.sub.2-A-CH.sub.2-E′).sub.n-π′-G  (1B) (where n is an integer of 2 to 5, A is a divalent perfluoropolyether group, π is an arylene group or a single bond, R is an alkenyl group or an alkynyl group, and E and E′ are each independently an ether bond or an ester bond or a group that is represented by a chemical formula
—O—CH.sub.2CH(OH)CH.sub.2O—
π′ is a group in which n+1 hydrogen atoms are separated from benzene, G is an organic group containing a fullerene skeleton, the n number of groups each of which is represented by a general formula
R-π-E-CH.sub.2-A-CH.sub.2-E′-
may be the same or different, and at least one π among the n number of π is an arylene group).

The present disclosure is directed to novel derivatives of citronellol and polycitronellol, particularly alkoxylated derivatives of citronellol and polycitronellol, and methods of making them, compositions comprising them, and methods for using them, particularly as surfactants.

Solid-polymer electrolytes, methods of making solid-polymer electrolytes, and uses of solid-polymer electrolytes. A solid-polymer electrolyte comprises a cross-linked polymer network. A cross-linked polymer network may comprise a plurality of groups, which may be cross-linked groups, such as, for example, cross-linked difunctional polyether groups, cross-linked difunctional ionic groups, non-crosslinked groups, which may be referred to as “dangling” groups, or a combination thereof, and a plurality of cross-linked multifunctional crosslinker groups. A solid polymer electrolyte can be formed by polymerization. A solid polymer electrolyte can be formed in situ in a device. A solid polymer electrolyte can be used in devices such as, for example, batteries, supercapacitors, fuel cells, and the like.

A higher secondary alcohol alkoxylate precursor is obtained by reacting a long-chain olefin with a (poly)alkylene glycol. The precursor has a content of (poly)alkylene glycol of 0.2% by mass or lower with respect to the total mass of the higher secondary alcohol alkoxylate; a higher secondary alcohol alkoxylate adduct which is an alkylene oxide adduct of the higher secondary alcohol alkoxylate precursor; and a higher secondary alkyl ether sulfate ester salt which is a sulfated product of the higher secondary alcohol alkoxylate precursor or the higher secondary alcohol alkoxylate adduct.

[Object]

To provide a derivative of a short chain fatty acid that can exhibit physiological functions inherent in the short chain fatty acid.

[Solution]

Provided is a block or graft copolymer including a hydrophobic segment of a repeat unit containing a short chain fatty acid ester that is hydrolyzable by esterase in vivo and a hydrophilic segment including a poly(ethylene glycol) chain. These copolymers are effective in the treatment or therapeutic treatment of various diseases or disorders, including cancer.

A polymer [polymer (P)] comprising a plurality of (per)fluoropolyether (PFPE) segments [segments (S.sup.RF)] joined together by hydrogenated (poly)ether segments [segments (S.sup.H)], said polymers (P) having two end groups [groups (E)], each group (E) comprising a hydroxy or a leaving group, with the proviso that the hydrogenated (polytether segment (S.sup.H) is not a segment of formula —CH.sub.2OCH.sub.2 2 OCH.sub.2— is herein disclosed. Disclosed is also a method for the manufacture of polymer (P) and a polymer obtainable by full or partial fluorination of polymer (P). Polymer (P) and polymers obtainable therefrom by full or partial fluorination can be conveniently used in the manufacture of lubricant compositions or of compositions for imparting hydro-/oleo-repellence to substrates. Said polymers can also be used as intermediates for the manufacture of other polymers or block copolymers.

The present invention relates to a hydrogel precursor formulation, its process of production as well as a kit comprising said formulation and a method of production of a hydrogel using said formulation. The precursor formulation comprises at least one structural compound, preferably vinyl sulfone (acrylated branched) poly(ethylene glycol), and at least one linker compound, preferably a peptide with two cysteines, wherein said structural compound and said linker compound are polymerizable by a selective reaction between a nucleophile and a conjugated unsaturated bond or group. The precursor formulation is in the form of a powder.